SCHEMBL3075327

SCHEMBL3075327

CC(=O)N(C)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21482179 0.85 LMNA (0.37)
SCHEMBL6685524 0.82
SCHEMBL992383 0.78
SCHEMBL14615688 0.76 LMNA (0.38)
SCHEMBL24248816 0.75
SCHEMBL13760604 0.75
SCHEMBL17075171 0.75
SCHEMBL10305562 0.75
SCHEMBL578060 0.73
Urea SCHEMBL9838387 0.72 LMNA (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101611015-A Indazolyl ester and indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders ASTRAZENECA AB (SE) 2009-12-23 CN claimed
US-6554886-B2 Urea compound and an inorganic acid and/or an organic acid supported on a porous support KURARAY CHEMICAL CO., LTD. (JP) 2003-04-29 US claimed
US-4410457-A EPOXY REACTIVE SOLVENT, EPOXY RESIN, LATENT HARDENER, EPOXIDE-DIALKYLAMINE ADDUCT SUMITOMO CHEMICAL CO., LTD. (JP) 1983-10-18 US claimed
US-4072712-A FROM ISOCYANATES, CATALYSIS BAYER AKTIENGESELLSCHAFT (DT) 1978-02-07 US claimed
US-20260146249-A1 ANTISENSE OLIGONUCLEOTIDES FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH AN ABNORMAL PROCESSING OF APP VICO THERAPEUTICS B.V. (NL) 2026-05-28 US disclosed
WO-2026099473-A1 OLIGONUCLEOTIDES WITH NEW INTERNUCLEOSIDE LINKAGE VICO THERAPEUTICS B.V. (NL) 2026-05-15 WO disclosed
EP-3921349-B1 PHENYL ISOCYANATE CONVERSION PROCESS DOW GLOBAL TECHNOLOGIES LLC (US) 2026-01-14 EP disclosed
US-12331293-B2 Bispecific antisense oligonucleotides for dystrophin exon skipping BIOMARIN TECHNOLOGIES B.V. (NL) 2025-06-17 US disclosed
EP-4562145-A1 ANTISENSE OLIGONUCLEOTIDES FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH AN ABNORMAL PROCESSING OF APP Vico Therapeutics B.V. (NL) 2025-06-04 EP disclosed
EP-4519437-A2 OLIGONUCLEOTIDE Academisch Ziekenhuis Leiden (h.o.d.n. LUMC) (NL) 2025-03-12 EP disclosed
US-20250011784-A1 RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS VICO THERAPEUTICS B V (NL) 2025-01-09 US disclosed
US-20240327840-A1 OLIGONUCLEOTIDE FOR INHIBITING QUAKING ACTIVITY ACADEMISCH ZIEKENHUIS LEIDEN (NL) 2024-10-03 US disclosed
EP-0430545-A2 Surface irradiation of articles molded from polypropylene compositions SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-06-05 EP disclosed
EP-0310622-A1 ANTI-INFLAMMATORY COMPOSITIONS. ALDER RES CENTER CORP (US) 1989-04-12 EP disclosed
WO-1987007599-A2 ANTI-INFLAMMATORY COMPOSITIONS ALDER RESEARCH CENTER CORPORATION (US) 1987-12-17 WO disclosed
EP-0039230-B1 CURABLE COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-12-11 EP disclosed
US-4410457-A EPOXY REACTIVE SOLVENT, EPOXY RESIN, LATENT HARDENER, EPOXIDE-DIALKYLAMINE ADDUCT SUMITOMO CHEMICAL CO., LTD. (JP) 1983-10-18 US disclosed
US-4360649-A EPOXY RESIN, EPOXIDE-DIALKYLAMINE ADDUCT, UREA COMPOUND, CURING AGENTS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-11-23 US disclosed
US-4272413-A Dialkylurea textile softening and antistatic agents COLGATE-PALMOLIVE COMPANY 1981-06-09 US disclosed
US-4072712-A FROM ISOCYANATES, CATALYSIS BAYER AKTIENGESELLSCHAFT (DT) 1978-02-07 US disclosed